Synergistic effect of combining dual enkephalinase inhibitor PL37 and sumatriptan in a preclinical model of migraine.
Saved in:
| Title: | Synergistic effect of combining dual enkephalinase inhibitor PL37 and sumatriptan in a preclinical model of migraine. |
|---|---|
| Authors: | Rossignol J; Neuro-Dol, Inserm, CHU Clermont-Ferrand, Université Clermont Auvergne, Clermont-Ferrand, France.; R & D Department, Pharmaleads SA, Paris, France., Ouimet T; R & D Department, Pharmaleads SA, Paris, France., Poras H; R & D Department, Pharmaleads SA, Paris, France., Dallel R; Neuro-Dol, Inserm, CHU Clermont-Ferrand, Université Clermont Auvergne, Clermont-Ferrand, France., Luccarini P; Neuro-Dol, Inserm, CHU Clermont-Ferrand, Université Clermont Auvergne, Clermont-Ferrand, France. |
| Source: | Headache [Headache] 2024 Mar; Vol. 64 (3), pp. 243-252. Date of Electronic Publication: 2024 Feb 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 2985091R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-4610 (Electronic) Linking ISSN: 00178748 NLM ISO Abbreviation: Headache Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1526-4610 |
|---|---|
| DOI: | 10.1111/head.14681 |
